2,2'-(1,4-Phenylene)bis(4H-3,1-benzoxazin-4-one)>98.0%(HPLC)(N)5g

4-BROMO-5-FLUORO-1,2-DIMETHOXYBENZENE, 97.0%, 1g

GC-Kapillarsäule ROTI®Cap-1701, L 60 m, Ø-Innen 0,32 mm, Filmd. 0,35 µm, 1 Stück

2-Iodo-4-nitroanisole, 98.0%, 100g

Dextran, Pharmaceutical grade,Mw64000-76000%, 500g

tert-Butyl 3-bromomethyl-indole-1-carboxylate, 95.0%, 2.5g

2-(3-Methylbut-2-enamido)-4-phenylthiophene-3-carboxylic acid, 97%, 250mg

BenzaMide, N-[3-[1,4-dihydro-1-Methyl-7-[(6-Methyl-3-pyridinyl)aMino]-2-oxopyriMido[4,5-d]pyriMidin-3(2H)-yl]-4-Methylphenyl]-3-(trifluoroMethyl)-, 97%, 50mg

Boc-L-Pyroglutaminol, 95.0%, 10g

METHYL 2-CYANO-5-METHOXY-3-METHYLBENZOATE, 97.0%, 1g

2-(4-Chloro-2-fluoro-3-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 5g

Hexafluoroisopropyl trifluoromethanesulfonate, 97.0%, 5g

(S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2,6-difluorophenyl)propanoic acid, 98%, 250mg